Muthuswamy S K, Li D, Lelievre S, Bissell M J, Brugge J S
Department of Cell Biology, Harvard Medical School, 240 Longwood Ave, Boston, MA 02115, USA.
Nat Cell Biol. 2001 Sep;3(9):785-92. doi: 10.1038/ncb0901-785.
Both ErbB1 and ErbB2 are overexpressed or amplified in breast tumours. To examine the effects of activating ErbB receptors in a context that mimics polarized epithelial cells in vivo, we activated ErbB1 and ErbB2 homodimers in preformed, growth-arrested mammary acini cultured in three-dimensional basement membrane gels. Activation of ErbB2, but not that of ErbB1, led to a reinitiation of cell proliferation and altered the properties of mammary acinar structures. These altered structures share several properties with early-stage tumours, including a loss of proliferative suppression, an absence of lumen, retention of the basement membrane and a lack of invasive properties. ErbB2 activation also disrupted tight junctions and the cell polarity of polarized epithelia, whereas ErbB1 activation did not have any effect. Our results indicate that ErbB receptors differ in their ability to induce early stages of mammary carcinogenesis in vitro and this three-dimensional model system can reveal biological activities of oncogenes that cannot be examined in vitro in standard transformation assays.
在乳腺肿瘤中,表皮生长因子受体1(ErbB1)和表皮生长因子受体2(ErbB2)均存在过表达或扩增现象。为了在模拟体内极化上皮细胞的环境中研究激活表皮生长因子受体(ErbB)的影响,我们在三维基底膜凝胶中培养的、预先形成的、生长停滞的乳腺腺泡中激活了ErbB1和ErbB2同型二聚体。激活ErbB2而非ErbB1会导致细胞增殖重新启动,并改变乳腺腺泡结构的特性。这些改变的结构与早期肿瘤具有一些共同特性,包括增殖抑制丧失、无管腔、基底膜保留以及缺乏侵袭性。ErbB2激活还破坏了极化上皮细胞的紧密连接和细胞极性,而ErbB1激活则没有任何影响。我们的结果表明,ErbB受体在体外诱导乳腺肿瘤发生早期阶段的能力存在差异,并且这种三维模型系统能够揭示在标准转化试验中无法在体外检测到的癌基因的生物学活性。